Long-term follow-up after Hearticellgram-AMI treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a long-term safety follow-up of patients with acute myocardial infarction who previously received a single administration of Hearticellgram-AMI. Participants will be monitored for 60 months with periodic clinic visits and medical record reviews to capture adverse events and clinical outcomes. Enrollment is limited to individuals who already received the product and who provide written informed consent. The follow-up is conducted at a single clinical site in Seoul to document long-term safety signals after approval.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Those who had administered Hearticellgram-AMI
2. Those who voluntarily agreed in writing to participate in this investigation

Exclusion Criteria:

\-

Where it's running

• KIMHYUNSOO Clinic
  Seoul, Gangnam, South Korea Recruiting

Study contacts

• Study coordinator: Daeun Jung
• Email: daeun4100@pharmicell.com
• Phone: 82-2-3496-0134

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients

  This pilot, noninvasive study tests whether the NIRSense wearable can help detect deterioration in adults with cardiogenic shock risk due to heart attack or heart failure.

  Recruiting NIRSense Inc. · Weston, Florida · NCT07825363

• Adenosine given before primary PCI to reduce no-reflow in STEMI patients.

  See if giving intracoronary adenosine before primary PCI lowers the chance of slow flow/no-reflow in adults with STEMI.

  Recruiting at 2 sites Phase 4 National Institute of Cardiovascular Diseases, Pakistan · Karachi, Sindh and 1 other locations · NCT07536802

• Subclinical depression in people after a first heart attack (SUBDIMA25)

  This project will test how common mild depressive symptoms are in adults hospitalized for a first heart attack and whether those symptoms relate to biomarkers, heart function, and recovery over the next year.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, Italia · NCT07492537

• Long-term remote ischemic preconditioning after a heart attack

  This trial will test whether daily brief arm blood‑flow restriction after a recent heart attack can lower the chance of major heart and brain events over the following year for people treated for acute myocardial infarction.

  Recruiting Henan Institute of Cardiovascular Epidemiology · Zhengzhou, Henan · NCT07181356

• Using wearable devices to monitor heart attack patients

  This study tests whether wearable devices can help monitor heart attack patients in the hospital to improve their care and predict their recovery.

  Recruiting RenJi Hospital · Shanghai · NCT06995495

• Assessing heart tissue damage in patients with heart aneurysms after a heart attack

  This study is testing how heart tissue damage looks in patients with heart aneurysms after a heart attack using special imaging to see if it helps understand their condition better.

  Recruiting RenJi Hospital · Shanghai · NCT06994221

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.